1. Home
  2. KTCC vs MRKR Comparison

KTCC vs MRKR Comparison

Compare KTCC & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Key Tronic Corporation

KTCC

Key Tronic Corporation

N/A

Current Price

$1.35

Market Cap

23.7M

Sector

Technology

ML Signal

N/A

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

N/A

Current Price

$0.92

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KTCC
MRKR
Founded
1969
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
19.5M
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
KTCC
MRKR
Price
$1.35
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.87
AVG Volume (30 Days)
24.0K
★ 182.9K
Earning Date
11-03-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.61
EPS
N/A
★ N/A
Revenue
★ $467,871,000.00
N/A
Revenue This Year
N/A
$19.61
Revenue Next Year
N/A
$375.85
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.44
$0.84
52 Week High
$4.42
$2.46

Technical Indicators

Market Signals
Indicator
KTCC
MRKR
Relative Strength Index (RSI) 12.45 43.00
Support Level N/A $0.88
Resistance Level $2.28 $1.32
Average True Range (ATR) 0.15 0.11
MACD -0.07 -0.00
Stochastic Oscillator 5.56 11.34

Price Performance

Historical Comparison
KTCC
MRKR

About KTCC Key Tronic Corporation

Key Tronic Corp is a contract manufacturer offering value-added design and manufacturing services from its facilities in the United States, Mexico, and Vietnam with procurement support from its facility in China. The company provides its customers full engineering services, materials management, manufacturing facilities, assembly services, in-house testing, and distribution. Its customers include original equipment manufacturers. Its capabilities are Printed Circuit Board Assembly, Injection Molding and Tooling, Metal Fabricating and Finishing, Full Product Assembly, Design and Engineering Support, and Logistics and Repair Center, and Supply Chain Management. It operates and internally manages a single operating segment, Electronics Manufacturing Services.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: